Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.48 |
| ▸ | RARB | P10826 | 9/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | RARA | P10276 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27968723 | 0.98 | TP53 (0.51) | TP53TSHRPLA2G4BRARBALDH1A1 | |
| SCHEMBL690293 | 0.94 | ALDH1A1 (0.44) | TP53TSHRALDH1A1MAPT | |
| SCHEMBL18817713 | 0.92 | TP53 (0.54) | TP53TSHRPLA2G4BRARBALDH1A1 | |
| SCHEMBL4938672 | 0.90 | TP53 (0.51) | TP53TSHRPLA2G4BRARBALDH1A1 | |
| SCHEMBL17982633 | 0.90 | TP53 (0.51) | TP53TSHRPLA2G4BRARBALDH1A1 | |
| SCHEMBL29716211 | 0.89 | CYP2D6 (0.49) | TP53TSHRALDH1A1 | |
| SCHEMBL29663544 | 0.88 | TP53 (0.47) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL270602 | 0.88 | TP53 (0.47) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL19856520 | 0.86 | PLA2G4B (0.44) | TP53TSHRPLA2G4BKMT2APLA2G4A | |
| SCHEMBL10004455 | 0.84 | PTPN11 (0.43) | TP53TSHRPLA2G4BRARBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565469-B2 | Method for ring hydrogenation of dialkyl terephthalates with low by-product formation | EVONIK OXENO GMBH & CO. KG (DE) | 2026-03-03 | — | — | US | claimed |
| US-11932749-B2 | Plasticizer composition comprising tripentyl esters of 1,2,4-cyclohexanetricarboxylic acid | EVONIK OXENO GMBH & CO. KG (DE) | 2024-03-19 | — | — | US | claimed |
| EP-4148038-B1 | METHOD FOR THE RING HYDROGENATION OF DIALKYL TEREPHTHALATES WITH LOW BY-PRODUCT FORMATION | EVONIK OXENO GMBH & CO KG (DE) | 2024-01-10 | — | — | EP | claimed |
| US-20230092962-A1 | METHOD FOR RING HYDROGENATION OF DIALKYL TEREPHTHALATES WITH LOW BY-PRODUCT FORMATION | EVONIK OPERATIONS GMBH (DE) | 2023-03-23 | — | — | US | claimed |
| CN-115806487-A | Cyclic hydrogenation of dialkyl terephthalates with low by-product formation | 赢创运营有限公司 | 2023-03-17 | — | — | CN | claimed |
| EP-4148038-A1 | METHOD FOR THE RING HYDROGENATION OF DIALKYL TEREPHTHALATES WITH LOW BY-PRODUCT FORMATION | Evonik Operations GmbH (DE) | 2023-03-15 | — | — | EP | claimed |
| US-20220411604-A1 | Plasticizer composition comprising tripentyl esters of 1,2,4-cyclohexanetricarboxylic acid | EVONIK OPERATIONS GMBH (DE) | 2022-12-29 | — | — | US | claimed |
| EP-4105272-A1 | SOFTENING COMPOSITION COMPRISING TRIPENTYL ESTER OF 1,2,4-CYCLOHEXANTRICARBOXYLIC ACID | Evonik Operations GmbH (DE) | 2022-12-21 | — | — | EP | claimed |
| CN-115477787-A | Plasticizer composition comprising tripentyl ester of 1,2, 4-cyclohexanetricarboxylic acid | 赢创运营有限公司 | 2022-12-16 | — | — | CN | claimed |
| US-20220314514-A1 | MOISTURE-CURABLE ADHESIVE COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY | 2022-10-06 | — | — | US | claimed |
| US-8822547-B2 | Hydroalcoholic gel compositions for use with dispensers | GOJO INDUSTRIES, INC. (US) | 2014-09-02 | — | — | US | claimed |
| EP-2460560-A1 | Hydroalcoholic gel compositions for use with dispensers | Gojo Industries, Inc. (US) | 2012-06-06 | — | — | EP | claimed |
| EP-2288416-B1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO IND INC (US) | 2012-02-29 | — | — | EP | claimed |
| US-20110281987-A1 | Polymer Compositions Comprising Terephthalates | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-11-17 | — | — | US | claimed |
| EP-2358801-A1 | POLYMER COMPOSITIONS COMPRISING TEREPHTHALATES | ExxonMobil Chemical Patents Inc. (US) | 2011-08-24 | — | — | EP | claimed |
| CN-102123764-A | Hydroalcoholic gel compositions for use with dispensers | GOJO IND INC | 2011-07-13 | — | — | CN | claimed |
| US-20110144214-A1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT | 2011-06-16 | — | — | US | claimed |
| EP-2288416-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO Industries, Inc. (US) | 2011-03-02 | — | — | EP | claimed |
| WO-2010071717-A1 | POLYMER COMPOSITIONS COMPRISING TEREPHTHALATES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-06-24 | — | — | WO | claimed |
| WO-2009058802-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO INDUSTRIES, INC. (US) | 2009-05-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144214-A1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | ADH1A, ADH1C, ADH5 | TP53 2684/4885TSHR 4450/4885PLA2G4B 1696/4885 |
| US-12565469-B2 | Method for ring hydrogenation of dialkyl terephthalates with low by-product formation | DDT, GRHPR, HPD | TP53 3401/4885TSHR 203/4885PLA2G4B 4501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.